baber/WOPTO huggingface dataset:
Patent CA-3088567-A1 (CA)
Title: Website creation system for creating websites having at least one series of directional webpages and related methods
Inventor: DICKERSON TODD
IPC: G06F16/957
Filed: 2019-01-22
Abstract: The present disclosure is directed towards systems and methods for creating a website and response actions via a website creation system. The systems and methods provide a plurality of website types for selection, and in response to receiving a selection of a website type, provide a plurality website templates specific to the selected website type. Each website type may include a series of directional webpages designed and intended to entice a particular user interaction with the website. Additionally, the systems and methods receiving a selection of a type of response action, a selection of at least one rule of a triggering condition, and an operand for the at least one rule of the triggering condition. Moreover, in response to the event of the triggering condition, the systems and method perform the response action.
Patent CA-3094078-A1 (CA)
Inventor: BHARTI KAPIL
IPC: G06K9/00
Filed: 2019-03-15
Abstract: A method is provided for non-invasively predicting characteristics of one or more cells and cell derivatives. The method includes training a machine learning model using at least one of a plurality of training cell images representing a plurality of cells and data identifying characteristics for the plurality of cells. The method further includes receiving at least one test cell image representing at least one test cell being evaluated, the at least one test cell image being acquired non-invasively and based on absorbance as an absolute measure of light, and providing the at least one test cell image to the trained machine learning model. Using machine learning based on the trained machine learning model, characteristics of the at least one test cell are predicted. The method further includes generating, by the trained machine learning model, release criteria for clinical preparations of cells based on the predicted characteristics of the at least one test cell.
Patent CA-3098760-A1 (CA)
Title: Variety corn line iax3374
Inventor: DELZER BRENT
IPC: A01H5/10
Filed: 2020-11-10
Abstract: ABSTRACT The present invention provides an inbred corn line designated IAX3374, methods for producing a corn plant by crossing plants of the inbred line IAX3374 with plants of another corn plant. The invention further encompasses all parts of inbred corn line IAX3374, including cells. The invention further provides uses of the inbred corn line IAX3374.  Additionally provided herein are methods for introducing transgenes into inbred corn line IAX3374, and plants produced according to these methods. Date Recue/Date Received 2020-11-10
Patent CA-3099181-A1 (CA)
Title: Procede et systeme de transmission de paquets de donnees a travers un canal de transmission (ra) a acces aleatoire
Inventor: ZAMOUM SELMA
IPC: H04W74/08
Filed: 2019-05-02
Abstract: The invention relates to a method and system for transmitting data packets via a random access (RA) transmission channel, shared by a plurality of user terminals, which uses and processes a function for attributing and distributing F transmission resources F(u) to the user terminals, whose knowledge of the graph is shared by the transmitting user terminals and the receiving station in a prior step. When decoding received packets, the graph {(u, F(u)} of the attribution and distribution function is processed by the receiving station (6) to minimise or even cancel the number of correlations for locating replicas required in the case of a blockage of the standard decoding process of the CRDSA protocol.
Patent CA-3099597-A1 (CA)
Title: Catalyst system, electrode, and fuel cell or electrolyzer with two-phase disperse oxide composite
Inventor: WEGENER MORITZ
IPC: H01M4/86
Filed: 2019-04-10
Abstract: The invention relates to a catalyst system, an electrode which comprises the catalyst system and a fuel cell or an electrolyzer having at least one such electrode. The catalyst system comprises an electrically conductive carrier metal oxide and an electrically conductive, metal oxide catalyst material, wherein the carrier metal oxide and the catalyst material differ in their composition and wherein the catalyst material and the carrier metal oxide are each stabilized with fluorine. A near-surface pH value, designated pzzp value (pzzp = point of zero zeta potential), of the carrier metal oxide and of the catalyst material differ from one another, wherein the pup value c]if either the carrier metal oxide or the catalyst material is at most pF- 5 The catalyst material arid the carrier metal oxide form an at least two-phase disperse oxide composite,
Patent CA-3104398-A1 (CA)
Title: Composes heterocycliques therapeutiques
Inventor: BARTLETT MARK J
IPC: C07D471/04
Filed: 2019-07-03
Abstract: L'iInvention concerne des composés ayant la formule suivante (I), ou un sel pharmaceutiquement acceptable ou un tautomère pharmaceutiquement acceptable de ceux-ci, et des procédés d'utilisation et de préparation de ceux-ci. Formule (I)
Patent CA-3104431-A1 (CA)
Title: Dispositif de melange d'aliments dote d'une fonction de calibrage
Inventor: GROOT STEFFEN CHRISTIAAN
IPC: A01K5/00
Filed: 2019-06-24
Abstract: Un dispositif de mélange d'aliments (1) pour recevoir, mélanger et distribuer des aliments pour animaux comprend un cadre (2) doté d'un bac de mélange (3) pour recevoir et mélanger lesdits aliments pour animaux en son sein et les distribuer à partir de celui-ci, au moins un dispositif de mélange (5) qui peut être entraîné en rotation dans le bac de mélange à l'aide d'un entraînement, en particulier d'une vis de mélange verticale (6), pour mélanger les aliments pour animaux reçus, et un dispositif de pesage pour déterminer le poids des aliments pour animaux reçus dans le bac de mélange, comprenant N éléments de pesage (9-1, 9-2), N = 2, chacun d'eux émettant un signal de pesage, et un système de commande (10) pour commander le dispositif de mélange d'aliments et pour traiter les signaux de pesage de la pluralité d'éléments de pesage pour produire le poids déterminé. Le système de commande est conçu pour effectuer une action d'étalonnage, en particulier entièrement automatique, desdits éléments de pesage. L'action d'étalonnage comprend l'entraînement du ou des dispositifs de mélange, la lecture du signal de pesage respectif de chacun des N éléments de pesage dans chacune de M positions différentes du dispositif de mélange, M = N, l'étalonnage des éléments de pesage sur la base des signaux de pesage lus, l'étalonnage comprenant au moins la détermination d'un facteur de correction respectif pour le signal de pesage de chaque élément de pesage par analyse des signaux de pesage lus de tous les éléments de pesage. Ainsi, tous les éléments de pesage peuvent être étalonnés sans avoir à détacher les éléments de pesage, ce qui permet des mesures de poids très fiables de manière très simple.
Patent CA-3105785-A1 (CA)
Inventor: DAVIES MICHAEL C
IPC: C10M169/04
Filed: 2018-07-17
Abstract: Compositions and methods are provided that generated a persistent low-friction coating on a solid surface, by application of a mixture of a polyethylene glycol-containing surfactant and a vegetable to the surface. The coating thus generated does not require replenishing during use and persists through rinsing and multiple uses. Surprisingly, markedly reduced friction is found when the surfactant is provided at 3% w/v to 7% w/v in the composition. Such compositions and methods are suitable for application to both mixing and separation operations. Formulation of such compositions with food grade components permits use in food processing.
Patent CA-3108578-A1 (CA)
Title: B*44 restricted peptides for use in immunotherapy against cancers and related methods
Inventor: SONG COLETTE
IPC: C07K7/06
Filed: 2019-09-17
Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
Patent CA-3109753-A1 (CA)
Title: Hinge assembly
Inventor: DOMAN MARTHINUS H
IPC: E05D7/00
Filed: 2021-02-20
Abstract: A hinge assembly for use on a structure having a first structure portion and a second structure portion. A first mounting plate configured to mount to the first structure portion and a second mounting plate configured to mount to the second structure portion. A hinge hingedly connecting the first mounting plate and the second mounting plate and configured to allow rotational movement of the first mounting plate and first structure portion relative to the second mounting plate and second structure portion between an open position and a closed position when the mounting plates are mounted to the corresponding structure portions. A  tightener acting between the first mounting plate and the second mounting plate, the tightener configured to pull the first mounting plate towards the second mounting plate.
Patent CA-3109781-A1 (CA)
Title: Bonded abrasive article including a filler comprising a nitride
Inventor: GASDASKA CHARLES J
IPC: C09G1/02
Filed: 2019-08-15
Abstract: Bonded abrasive articles typically contain abrasive particles held together by a bond material. An improved bonded abrasive articles which have a bond chemistry that provides desired mechanical stability and strength is in demand. An abrasive article can include a body including a bond material comprising vitreous material is provided. The abrasive particles having an average particle size (D50AP) and a filler comprising a nitride having an average particle size (D50F) can compensate shrinkage of the body during sintering while maintaining required strength and wear properties of the body by having a filler-to-abrasive particle size ratio (D50F/D50AP) within a range of at least 0.01 and less than 0.5.
Patent CA-3114061-A1 (CA)
Title: Liquid polymer delivery system for extended administration of drugs
Inventor: VAN HOVE AMY HALLER
IPC: A61P15/10
Filed: 2019-09-24
Abstract: Liquid polymer pharmaceutical compositions comprising a biodegradable liquid polymer, a biocompatible solvent system, and an active pharmaceutical ingredient (API) are disclosed. The compositions of the invention are useful for providing extended, long-term release of the API.
Patent CA-3115811-A1 (CA)
Inventor: SATISH SIDDARTH
IPC: G06T7/33
Filed: 2019-10-14
Abstract: L'invention concerne un système de traitement d'une image d'un code lisible par machine. Le procédé comprend la réception d'une image d'un code lisible par machine comprenant des informations codées, le code lisible par machine étant au moins partiellement caché par une substance qui a une couleur prédominante ; la génération d'une image ajustée par ajustement d'un espace de couleur de l'image sur la base de la couleur prédominante ; la binarisation d'au moins une région de code lisible par machine de l'image, la région de code lisible par machine de l'image représentant le code lisible par machine ; et le décodage de la région de code lisible par machine binarisée pour déterminer les informations codées. L'invention concerne également d'autres appareils et procédés.
Patent CA-3119177-A1 (CA)
Title: Optical fluidic methods for a rheometer
Inventor: JAMISON DALE E
IPC: G01N11/14
Filed: 2019-01-31
Abstract: Systems and methods of the disclosed embodiments include a rheometer having a housing with a fluid inlet and a fluid outlet, a cylinder with a cavity located to receive fluid that passes into the fluid inlet, a motor configured to rotate the cylinder, a torsion bob within the cavity, and a controller located remotely from the rheometer. The controller includes a pressure regulator configured to pressurize fluid to power the motor, a rotation sensor configured to receive an optical rotation signal indicating a rotation speed of the cylinder, and a torque sensor configured to receive an optical signal indicating a torque on the torsion bob. The controller may be configured to receive a rotation speed signal from the rotation sensor, a torque signal from the torque sensor, and to calculate a shear stress for the fluid based on the rotation speed signal and the torque signal.
Patent CA-3119704-A1 (CA)
Title: Ensemble de panneaux de construction et procede de fabrication
Inventor: EDWARDS NICHOLAS
IPC: E04C2/296
Filed: 2019-11-15
Abstract: L'invention concerne des ensembles de panneaux de construction destinés à être utilisés dans la construction de nouvelles maisons, de bâtiments commerciaux et de panneau structurel isolé (SIP) rectangulaire en copeaux extensible (10). Lesdits ensembles de panneaux de construction comprennent une paire de plaques espacées (12',12''), un noyau isolant interne (13) et un cadre rigide externe périphérique à profil bas (14), de préférence en métal, par exemple en acier, s'étendant autour de la périphérie entière des plaques espacées (12',12''). Fig. 1
Patent CA-3119789-A1 (CA)
Title: Amino acid derivatives functionalized on the n-terminal capable of forming drug encapsulating microspheres
Inventor: DONG YIZHOU
IPC: C09K23/32
Filed: 2012-10-26
Abstract: Abstract Described herein are compounds and compositions that are characterized by the Markush formulae (I), (II), (III), (IV), (V), and (VI) underneath, where at least one terminal amino group is further functionalized by bearing a group of type (i), (ii) or (iii). Such compounds are obtained by reacting a terminal or internal amino group with epoxides, acrylates, or aldehydes bearing lipophilic groups. The resulting amino acid, peptide, polypeptide-lipids (named "APPLs" in the application) are deemed useful as drug delivery systems including nucleotide delivery to cells.  Formulae (i), (ii), and (iii). Date Recue/Date Received 2021-05-27
Patent CA-3119829-A1 (CA)
Title: System and method for authorizing access to access-controlled environments
Inventor: HOYOS HECTOR
IPC: H04W12/72
Filed: 2014-05-13
Abstract: ABSTRACT Systems and methods are provided for authorizing a user to access an access- controlled environment. The system includes a system server platform that communicates with fixed PC's, servers and mobile devices (e.g., smartphones) operated by users. The systems and methods described herein enable a series of operations whereby a user attempting to access an access- controlled environment is prompted to biometrically authenticate using the user's preregistered mobile device. Biometric authentication can include capturing images of the user's biometric features, encoding the features as a biometric indentifier, comparing the biometric identifier to a previously generated biometric identifier and determining liveness. In addition, the authentication system can further authorize the user and electronically grant access to the access-controlled environment. In this manner the secure authentication system can, based on biometric authentication, authorize a user's access to devices, online services, physical locations or any networked environment that require user authorization. Date Recue/Date Received 2021-05-27
Patent CA-3119875-A1 (CA)
Title: Graft-mediated hybridisation of monocotyledonous plants
Inventor: REEVES GREGORY
IPC: A01H1/06
Filed: 2019-11-14
Abstract: The invention relates to the production of graft-mediated hybrid monocotyledonous plants. Methods for the production of such plants are disclosed herein.
Patent CA-3121964-A1 (CA)
Title: Aqueous alkaline pre-treatment solution for use prior to deposition of a palladium activation layer, method and use thereof
Inventor: BREMMERT STEFANIE
IPC: C23C18/20
Filed: 2019-10-07
Abstract: The invention relates to an aqueous alkaline pre-treatment solution for use prior to deposition of a palladium activation layer on a substrate in manufacturing an article with an integrated circuit and a method and use thereof, wherein the solution comprises: - at least one hydroxycarboxylic acid or salt thereof according to the general formula (I) [RCH2-(RCH)n-COO-]m Mm+ (I) wherein n is integer from 2 to 4 and m is 1 or 2, R is independently H or OH with proviso that at least one R is OH, and wherein Mm+ with m: 1 is hydrogen, ammonium or alkali metal; or Mm+ with m: 2 is earth alkali metal, - at least one polyoxyethylene sorbitan fatty acid ester, - at least one sulphonated fatty acid or a salt thereof.
Patent CA-3127470-A1 (CA)
Title: Use of ppar-delta agonists in the treatment of mitochondrial myopathy
Inventor: O'CARROLL COLIN
IPC: C07H21/04
Filed: 2020-02-20
Abstract: Described herein is the use of PPAR6 agonists in the treatment of mitochondrial myopathy. In one aspect, described herein are methods for treating a primary mitochondrial myopathy (PMM) in a mammal comprising administering to the mammal with a primary mitochondrial myopathy a peroxisome proliferator-activated receptor delta (PPAR6) agonist compound. In another aspect, described herein is a method of modulating PPAR6 in a mammal with primary mitochondrial myopathy comprising administering to the mammal with primary mitochondrial myopathy PPAR6 agonist compound.
Patent CA-3129092-A1 (CA)
Inventor: MARTINEZ-MONTEMAYOR MICHELLE
IPC: A61K31/56
Filed: 2020-02-06
Abstract: The bioactive compounds of Ganoderma lucidum extract (GLE) responsible for anticancer activity were elucidated using NMR, X-ray crystallography and analogue derivatization, as well as anti-cancer activity studies. Structures of the seven most abundant GLE compounds are disclosed. Their selective efficacy against triple negative (TNBC) and inflammatory breast cancers (IBC) and other human cancer cell types (solid and blood malignancies) was shown, confirming potential their as anticancer agents.
Patent CA-3129169-A1 (CA)
Inventor: BARTELLA LUIGI
IPC: E04B9/00
Filed: 2020-02-24
Abstract: La présente invention concerne d'une manière générale des panneaux acoustiques, par exemple, appropriés pour des surfaces de plafond acoustiques. La présente invention concerne plus particulièrement des panneaux acoustiques comprenant un corps de panneau (par exemple, comprenant de la fibre de verre, ou ayant une valeur NRC dans la plage d'au moins 0,5, par exemple, 0,5 à 0,95 ou 0,5 à 0,9) et un cadre périphérique s'étendant autour d'un bord latéral du corps de panneau. Le cadre périphérique comprend une pluralité d'éléments de cadre comprenant un premier élément de cadre et un second élément de cadre. Un premier adhésif lie les éléments de cadre au corps de panneau. Un second adhésif ayant un temps de travail plus court peut également lier les éléments de cadre au corps de panneau. De plus, ou en variante, un support qui rassemble les éléments de cadre les uns aux autres comprend une saillie pointue qui empêche le retrait du support des éléments de cadre une fois assemblés. Ces aspects permettent de manipuler le panneau acoustique avant que le premier adhésif ne soit durci.
Patent CA-3131819-A1 (CA)
Inventor: YAN BO
IPC: A61M5/32
Filed: 2020-03-03
Abstract: The removing device (1) is configured to remove a needle cover (102) removably mounted on a distal tip of an injection device (100) comprising a barrel (104). The removing device (1) comprises a housing (2) including a holder (4) configured to hold the injection device (100) and a needle cover remover (6) configured to remove the needle cover (102) from the injection device (100), a first abutment member provided on the holder (4) and being configured to abut against said injection device (100), a second abutment member provided on the needle cover remover (6), and being configured to abut against the needle cover (102), and displacement means configured to displace the needle cover remover (6) relative to the holder (4) in a translational direction so that the first and second abutment members translationally move away from each other in order to separate the needle cover (102) from the injection device (100)..
Patent CA-3132260-A1 (CA)
Inventor: THOMASSIN JEAN
IPC: B64D27/02
Filed: 2019-12-09
Abstract: La présente invention concerne un système de propulsion d'aéronef comprenant deux centrales électriques comprenant une centrale électrique à combustion sur une aile de l'aéronef et une centrale électrique hybride sur l'autre aile de l'aéronef, la centrale électrique à combustion comprenant un turbopropulseur à turbine à gaz et la centrale électrique hybride comprenant un moteur thermique et un moteur électrique qui sont agencés soit dans une configuration d'entraînement parallèle soit dans une configuration d'entraînement en ligne.
Patent CA-3132380-A1 (CA)
Inventor: LINDBERG BRAENDON R
IPC: F16D7/02
Filed: 2020-03-06
Abstract: La présente invention concerne un module à embrayage ne pouvant pas être entraîné en sens inverse pour un actionneur bidirectionnel, tel que des actionneurs utilisés pour une aérodynamique active sur des véhicules. Le module présente à la fois un mode d'arrêt et un mode d'embrayage. Pendant le mode d'arrêt, une force d'entraînement en sens inverse est déviée à l'écart de l'actionneur à l'aide d'un élément de support de verrouillage. Si la force est trop élevée, un mode d'embrayage libérera complètement la force d'entraînement en sens inverse de l'arbre relié à l'actionneur, ce qui empêche un endommagement de l'actionneur.
Patent CA-3133120-A1 (CA)
Inventor: GATALO MATIJA
IPC: B01J23/72
Filed: 2020-03-17
Abstract: The present invention concerns a double passivation galvanic displacement (GD) synthesis method for production of high performance, supported noble metal-M alloy composite material, where M is an electrochemically less noble metal, compared to the noble metal, the supported noble metal-M alloy composite material obtained by the synthesis, and the use of such composite material as electrocatalyst material.
Patent CA-3134836-A1 (CA)
Inventor: KELLY SCOTT
IPC: C07K16/10
Filed: 2020-04-01
Abstract: The present disclosure relates to the use of DNA damaging agents and leronlimab (PRO 140), or other anti-CCR5 agents, to treat or prevent cancer metastases and enhance the cell killing ability of the DNA damaging agents by selectively targeting the CCR5 receptor. The present disclosure relates to the use of DNA damaging agents and leronlimab (PRO 140), or other anti-CCR5 agents, to treat or prevent cancer metastases and reduce circulating tumor cells (CTC) or putative metastatic tumor cells in the peripheral blood following treatment,.reduce CCR5 expression on cancer-associated cells after following treatment, decrease volume in tumor size following treatment. The present disclosure may be used to treat or prevent subjects with cancer and, particularly, subjects with metastatic CCR5+ cancer.
Patent CA-3135382-A1 (CA)
Inventor: ZIRAN JUSTIN
IPC: A63F3/00
Filed: 2020-04-01
Abstract: A tile game system is provided that includes a plurality of two-dimensional and three-dimensional components. The two-dimensional components can include a plurality of modular tiles provided in various sizes and configurations that can be joined together to form a grid-based gameplay area. The three-dimensional components can include external boundaries for the gameplay area, internal boundaries, terrain elements such as columns and staircases, and game figures. According to aspects of the present disclosure, the external and internal boundaries can be provided with recessed sections that allow a game figure to be contained within a single grid square and prevent the grid of the gameplay area from becoming warped. According to some aspects of the present disclosure the internal and external boundaries can be illuminated and provided with removable and interchangeable light-permeable skins that allow a user to switch between various illuminated designs.